{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T19:33:07Z","timestamp":1768678387178,"version":"3.49.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070679"],"award-info":[{"award-number":["82070679"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2022JJ30813"],"award-info":[{"award-number":["2022JJ30813"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2020JJ4804"],"award-info":[{"award-number":["2020JJ4804"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019091","name":"Key Research and Development Program of Hunan Province of China","doi-asserted-by":"publisher","award":["2022SK2040"],"award-info":[{"award-number":["2022SK2040"]}],"id":[{"id":"10.13039\/501100019091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Non-alcoholic fatty liver disease (NAFLD) is a metabolic disorder with abnormal lipid metabolism. The present study was to identify regulatory genes related to lipid droplets (LDs) abnormal accumulation in NAFLD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>transcriptomic analysis and bioinformatics analysis (GEO database) were used to identify potential genes in abnormal lipid metabolism of NAFLD. A candidate gene <jats:italic>MAP3K4<\/jats:italic> expression were detected by immunohistochemistry staining in NAFLD and controls. RNA interference and immunoblotting were used to verify the roles of <jats:italic>MAP3K4<\/jats:italic> in the formation of hepatic LDs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 134 candidate genes were screened, including 44 up-regulated genes and 90 down-regulated genes. 29 genes in the protein\u2013protein interaction (PPI) were selected as hub genes, including <jats:italic>MAP3K4<\/jats:italic>. The expression levels of <jats:italic>MAP3K4<\/jats:italic> were positively correlated with NAFLD activity score (r\u2009=\u20090.702, p\u2009=\u20090.002). Furthermore, we found a positive correlation of MAP3K4 expression with serum total cholesterol (r\u2009=\u20090.564, p\u2009=\u20090.023), uric acid levels (r\u2009=\u20090.520, p\u2009=\u20090.039), and body mass index (r\u2009=\u20090.574, p\u2009=\u20090.020). Downregulation of <jats:italic>MAP3K4<\/jats:italic> decreased LDs accumulation in HepG2 cells and reduced the expression of CGI-58 and Plin-2 by imbibition of JNK and group IVA cytosolic phospholipase A2 (cPLA2) activation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The study revealed a number of regulatory genes related to hepatic lipid metabolism of NAFLD, and demonstrated that <jats:italic>MAP3K4<\/jats:italic> played a pivotal role in the hepatic lipogenesis of NAFLD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-022-03734-8","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T17:02:52Z","timestamp":1668445372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Identification of MAP3K4 as a novel regulation factor of hepatic lipid metabolism in non-alcoholic fatty liver disease"],"prefix":"10.1186","volume":"20","author":[{"given":"Zhiyong","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Bin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangshun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenling","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junfang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5285-2403","authenticated-orcid":false,"given":"Jiequn","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,14]]},"reference":[{"issue":"7","key":"3734_CR1","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1503\/cmaj.045232","volume":"172","author":"LA Adams","year":"2005","unstructured":"Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. CMAJ. 2005;172(7):899\u2013905.","journal-title":"CMAJ"},{"issue":"1","key":"3734_CR2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/s12967-020-02637-w","volume":"18","author":"X Yuan","year":"2020","unstructured":"Yuan X, Diao J, Du A, Wen S, Zhou L, Pan Y. Circular RNA expression profiles and features in NAFLD mice: a study using RNA-seq data. J Transl Med. 2020;18(1):476.","journal-title":"J Transl Med"},{"issue":"2","key":"3734_CR3","doi-asserted-by":"publisher","first-page":"206","DOI":"10.5009\/gnl20127","volume":"15","author":"S Murag","year":"2021","unstructured":"Murag S, Ahmed A, Kim D. Recent epidemiology of nonalcoholic fatty liver disease. Gut Liver. 2021;15(2):206\u201316.","journal-title":"Gut Liver"},{"issue":"5","key":"3734_CR4","doi-asserted-by":"publisher","first-page":"537","DOI":"10.5009\/gnl19236","volume":"14","author":"M Tobari","year":"2020","unstructured":"Tobari M, Hashimoto E. Characteristic features of nonalcoholic fatty liver disease in Japan with a focus on the roles of age, sex and body mass index. Gut Liver. 2020;14(5):537\u201345.","journal-title":"Gut Liver"},{"issue":"3","key":"3734_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM. Non-alcoholic fatty liver disease\u2014a global public health perspective. J Hepatol. 2019;70(3):531\u201344.","journal-title":"J Hepatol"},{"key":"3734_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.21037\/tgh.2019.12.05","volume":"5","author":"KE Robinson","year":"2020","unstructured":"Robinson KE, Shah VH. Pathogenesis and pathways: nonalcoholic fatty liver disease & alcoholic liver disease. Transl Gastroenterol Hepatol. 2020;5:49.","journal-title":"Transl Gastroenterol Hepatol"},{"key":"3734_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104984","volume":"159","author":"CH Zhang","year":"2020","unstructured":"Zhang CH, Zhou BG, Sheng JQ, Chen Y, Cao YQ, Chen C. Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategies. Pharmacol Res. 2020;159: 104984.","journal-title":"Pharmacol Res"},{"key":"3734_CR8","doi-asserted-by":"publisher","first-page":"5936171","DOI":"10.1155\/2017\/5936171","volume":"2017","author":"XY Guo","year":"2017","unstructured":"Guo XY, He CX, Wang YQ, Sun C, Li GM, Su Q, et al. Circular RNA profiling and bioinformatic modeling identify its regulatory role in hepatic steatosis. Biomed Res Int. 2017;2017:5936171.","journal-title":"Biomed Res Int"},{"issue":"1","key":"3734_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.diabet.2012.11.002","volume":"39","author":"K Gariani","year":"2013","unstructured":"Gariani K, Philippe J, Jornayvaz FR. Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside. Diabetes Metab. 2013;39(1):16\u201326.","journal-title":"Diabetes Metab"},{"key":"3734_CR10","doi-asserted-by":"publisher","first-page":"6889533","DOI":"10.1155\/2021\/6889533","volume":"2021","author":"T Hong","year":"2021","unstructured":"Hong T, Chen Y, Li X, Lu Y. The role and mechanism of oxidative stress and nuclear receptors in the development of NAFLD. Oxid Med Cell Longev. 2021;2021:6889533.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"3734_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/hep.29465","volume":"67","author":"M Gaggini","year":"2018","unstructured":"Gaggini M, Carli F, Rosso C, Buzzigoli E, Marietti M, Della Latta V, et al. Altered amino acid concentrations in NAFLD: impact of obesity and insulin resistance. Hepatology. 2018;67(1):145\u201358.","journal-title":"Hepatology"},{"key":"3734_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10020174","author":"JC Arroyave-Ospina","year":"2021","unstructured":"Arroyave-Ospina JC, Wu Z, Geng Y, Moshage H. Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease: implications for prevention and therapy. Antioxidants (Basel). 2021. https:\/\/doi.org\/10.3390\/antiox10020174.","journal-title":"Antioxidants (Basel)"},{"issue":"34","key":"3734_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202102391","volume":"33","author":"C Zhao","year":"2021","unstructured":"Zhao C, Li Z, Chen J, Su L, Wang J, Chen DS, et al. Site-specific biomimicry of antioxidative melanin formation and its application for acute liver injury therapy and imaging. Adv Mater. 2021;33(34): e2102391.","journal-title":"Adv Mater"},{"issue":"40","key":"3734_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201902956","volume":"31","author":"D Ni","year":"2019","unstructured":"Ni D, Wei H, Chen W, Bao Q, Rosenkrans ZT, Barnhart TE, et al. Ceria nanoparticles meet hepatic ischemia-reperfusion injury: the perfect imperfection. Adv Mater. 2019;31(40): e1902956.","journal-title":"Adv Mater"},{"issue":"3","key":"3734_CR15","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.7150\/thno.38834","volume":"10","author":"S Li","year":"2020","unstructured":"Li S, Li H, Xu X, Saw PE, Zhang L. Nanocarrier-mediated antioxidant delivery for liver diseases. Theranostics. 2020;10(3):1262\u201380.","journal-title":"Theranostics"},{"issue":"1","key":"3734_CR16","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1038\/s41467-022-29772-w","volume":"13","author":"J Mu","year":"2022","unstructured":"Mu J, Li C, Shi Y, Liu G, Zou J, Zhang DY, et al. Protective effect of platinum nano-antioxidant and nitric oxide against hepatic ischemia-reperfusion injury. Nat Commun. 2022;13(1):2513.","journal-title":"Nat Commun"},{"issue":"11","key":"3734_CR17","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s11094-018-1724-6","volume":"51","author":"A Eftekhari","year":"2018","unstructured":"Eftekhari A, Ahmadian E, Azarmi Y, Parvizpur A, Fard JK, Eghbal MA. The effects of cimetidine, N-acetylcysteine, and taurine on thioridazine metabolic activation and induction of oxidative stress in isolated rat hepatocytes. Pharm Chem J. 2018;51(11):965\u20139.","journal-title":"Pharm Chem J"},{"issue":"4","key":"3734_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1055\/s-0042-123034","volume":"67","author":"E Ahmadian","year":"2017","unstructured":"Ahmadian E, Babaei H, Mohajjel Nayebi A, Eftekhari A, Eghbal MA. Mechanistic approach for toxic effects of bupropion in primary rat hepatocytes. Drug Res (Stuttg). 2017;67(4):217\u201322.","journal-title":"Drug Res (Stuttg)"},{"key":"3734_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.freeradbiomed.2020.02.029","volume":"152","author":"J Yan","year":"2020","unstructured":"Yan J, Jiang J, He L, Chen L. Mitochondrial superoxide\/hydrogen peroxide: an emerging therapeutic target for metabolic diseases. Free Radic Biol Med. 2020;152:33\u201342.","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"3734_CR20","doi-asserted-by":"publisher","first-page":"436","DOI":"10.4254\/wjh.v12.i8.436","volume":"12","author":"S Kartsoli","year":"2020","unstructured":"Kartsoli S, Kostara CE, Tsimihodimos V, Bairaktari ET, Christodoulou DK. Lipidomics in non-alcoholic fatty liver disease. World J Hepatol. 2020;12(8):436\u201350.","journal-title":"World J Hepatol"},{"issue":"19","key":"3734_CR21","doi-asserted-by":"publisher","first-page":"9521","DOI":"10.1073\/pnas.1901974116","volume":"116","author":"S BasuRay","year":"2019","unstructured":"BasuRay S, Wang Y, Smagris E, Cohen JC, Hobbs HH. Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis. Proc Natl Acad Sci USA. 2019;116(19):9521\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"3734_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","volume":"76","author":"F Bessone","year":"2019","unstructured":"Bessone F, Razori MV, Roma MG. Molecular pathways of nonalcoholic fatty liver disease development and progression. Cell Mol Life Sci. 2019;76(1):99\u2013128.","journal-title":"Cell Mol Life Sci"},{"issue":"31","key":"3734_CR23","doi-asserted-by":"publisher","first-page":"12780","DOI":"10.1073\/pnas.1311176110","volume":"110","author":"T Galbo","year":"2013","unstructured":"Galbo T, Perry RJ, Jurczak MJ, Camporez JP, Alves TC, Kahn M, et al. Saturated and unsaturated fat induce hepatic insulin resistance independently of TLR-4 signaling and ceramide synthesis in vivo. Proc Natl Acad Sci USA. 2013;110(31):12780\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"3734_CR24","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1172\/JCI43378","volume":"121","author":"WL Holland","year":"2011","unstructured":"Holland WL, Bikman BT, Wang LP, Yuguang G, Sargent KM, Bulchand S, et al. Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J Clin Invest. 2011;121(5):1858\u201370.","journal-title":"J Clin Invest"},{"issue":"11","key":"3734_CR25","doi-asserted-by":"publisher","first-page":"9887","DOI":"10.1074\/jbc.M410310200","volume":"280","author":"JM Schattenberg","year":"2005","unstructured":"Schattenberg JM, Wang Y, Singh R, Rigoli RM, Czaja MJ. Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling. J Biol Chem. 2005;280(11):9887\u201394.","journal-title":"J Biol Chem"},{"issue":"9","key":"3734_CR26","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1097\/MEG.0b013e328328f461","volume":"21","author":"E Kathirvel","year":"2009","unstructured":"Kathirvel E, Morgan K, French SW, Morgan TR. Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2009;21(9):973\u201383.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"10","key":"3734_CR27","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1124\/dmd.115.065979","volume":"43","author":"SJ Woolsey","year":"2015","unstructured":"Woolsey SJ, Mansell SE, Kim RB, Tirona RG, Beaton MD. CYP3A activity and expression in nonalcoholic fatty liver disease. Drug Metab Dispos. 2015;43(10):1484\u201390.","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"3734_CR28","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","volume":"68","author":"M Eslam","year":"2018","unstructured":"Eslam M, Valenti L, Romeo S. Genetics and epigenetics of NAFLD and NASH: clinical impact. J Hepatol. 2018;68(2):268\u201379.","journal-title":"J Hepatol"},{"issue":"9","key":"3734_CR29","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrendo.2015.117","volume":"11","author":"A Garten","year":"2015","unstructured":"Garten A, Schuster S, Penke M, Gorski T, de Giorgis T, Kiess W. Physiological and pathophysiological roles of NAMPT and NAD metabolism. Nat Rev Endocrinol. 2015;11(9):535\u201346.","journal-title":"Nat Rev Endocrinol"},{"key":"3734_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105879","volume":"173","author":"Y Dong","year":"2021","unstructured":"Dong Y, Ma N, Fan L, Yuan L, Wu Q, Gong L, et al. GADD45beta stabilized by direct interaction with HSP72 ameliorates insulin resistance and lipid accumulation. Pharmacol Res. 2021;173: 105879.","journal-title":"Pharmacol Res"},{"issue":"1","key":"3734_CR31","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41598-020-79948-x","volume":"11","author":"JA Levine","year":"2021","unstructured":"Levine JA, Oleaga C, Eren M, Amaral AP, Shang M, Lux E, et al. Role of PAI-1 in hepatic steatosis and dyslipidemia. Sci Rep. 2021;11(1):430.","journal-title":"Sci Rep"},{"key":"3734_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.589206","volume":"12","author":"CH Lee","year":"2021","unstructured":"Lee CH, Lui DTW, Lam KSL. Adipocyte fatty acid-binding protein cardiovascular diseases and mortality. Front Immunol. 2021;12: 589206.","journal-title":"Front Immunol"},{"issue":"6","key":"3734_CR33","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313\u201321.","journal-title":"Hepatology"},{"issue":"10","key":"3734_CR34","doi-asserted-by":"publisher","first-page":"13776","DOI":"10.1096\/fj.202001067R","volume":"34","author":"Z Si","year":"2020","unstructured":"Si Z, Guan X, Teng X, Peng X, Wan Z, Li Q, et al. Identification of CYP46A1 as a new regulator of lipid metabolism through CRISPR-based whole-genome screening. FASEB J. 2020;34(10):13776\u201391.","journal-title":"FASEB J"},{"key":"3734_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.741710","volume":"9","author":"Y Ma","year":"2021","unstructured":"Ma Y, Tan Z, Li Q, Fan W, Chen G, Bin Y, et al. Combined analysis of expression profiles in a mouse model and patients identified BHMT2 as a new regulator of lipid metabolism in metabolic-associated fatty liver disease. Front Cell Dev Biol. 2021;9: 741710.","journal-title":"Front Cell Dev Biol"},{"key":"3734_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2022.03.055","volume":"605","author":"Y Ma","year":"2022","unstructured":"Ma Y, Li Q, Chen G, Tan Z, Cao H, Bin Y, et al. Transcriptomic analysis reveals a novel regulatory factor of ECHDC1 involved in lipid metabolism of non-alcoholic fatty liver disease. Biochem Biophys Res Commun. 2022;605:1\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"3734_CR37","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2105-4-2","volume":"4","author":"GD Bader","year":"2003","unstructured":"Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics. 2003;4:2.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"3734_CR38","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.dsx.2014.09.015","volume":"9","author":"C Janani","year":"2015","unstructured":"Janani C, Ranjitha Kumari BD. PPAR gamma gene\u2013a review. Diabetes Metab Syndr. 2015;9(1):46\u201350.","journal-title":"Diabetes Metab Syndr"},{"issue":"Suppl 1","key":"3734_CR39","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.5604\/01.3001.0010.5493","volume":"16","author":"A Di Ciaula","year":"2017","unstructured":"Di Ciaula A, Garruti G, Lunardi Baccetto R, Molina-Molina E, Bonfrate L, Wang DQ, et al. Bile acid physiology. Ann Hepatol. 2017;16(Suppl 1):S4\u201314.","journal-title":"Ann Hepatol"},{"issue":"5","key":"3734_CR40","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","volume":"68","author":"T Jensen","year":"2018","unstructured":"Jensen T, Abdelmalek MF, Sullivan S, Nadeau KJ, Green M, Roncal C, et al. Fructose and sugar: a major mediator of non-alcoholic fatty liver disease. J Hepatol. 2018;68(5):1063\u201375.","journal-title":"J Hepatol"},{"key":"3734_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32456","author":"L Lei","year":"2022","unstructured":"Lei L, Bruneau A, El Mourabit H, Guegan J, Folseraas T, Lemoinne S, et al. Portal fibroblasts with mesenchymal stem cell features form a reservoir of proliferative myofibroblasts in liver fibrosis. Hepatology. 2022. https:\/\/doi.org\/10.1002\/hep.32456.","journal-title":"Hepatology"},{"issue":"1","key":"3734_CR42","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3390\/ijms16010924","volume":"16","author":"C Huang","year":"2015","unstructured":"Huang C, Freter C. Lipid metabolism, apoptosis and cancer therapy. Int J Mol Sci. 2015;16(1):924\u201349.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3734_CR43","doi-asserted-by":"publisher","first-page":"7037","DOI":"10.1038\/s41467-021-27307-3","volume":"12","author":"M Lacroix","year":"2021","unstructured":"Lacroix M, Linares LK, Rueda-Rincon N, Bloch K, Di Michele M, De Blasio C, et al. The multifunctional protein E4F1 links P53 to lipid metabolism in adipocytes. Nat Commun. 2021;12(1):7037.","journal-title":"Nat Commun"},{"issue":"11","key":"3734_CR44","doi-asserted-by":"publisher","first-page":"3634","DOI":"10.3390\/ijms19113634","volume":"19","author":"X Cui","year":"2018","unstructured":"Cui X, Qian DW, Jiang S, Shang EX, Zhu ZH, Duan JA. Scutellariae radix and coptidis rhizoma improve glucose and lipid metabolism in T2DM rats via regulation of the metabolic profiling and MAPK\/PI3K\/Akt signaling pathway. Int J Mol Sci. 2018;19(11):3634.","journal-title":"Int J Mol Sci"},{"issue":"25","key":"3734_CR45","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.3748\/wjg.v24.i25.2661","volume":"24","author":"T Kanda","year":"2018","unstructured":"Kanda T, Matsuoka S, Yamazaki M, Shibata T, Nirei K, Takahashi H, et al. Apoptosis and non-alcoholic fatty liver diseases. World J Gastroenterol. 2018;24(25):2661\u201372.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"3734_CR46","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.rbmo.2016.07.011","volume":"33","author":"J Jia","year":"2016","unstructured":"Jia J, Gou J, Zhao X, Yi T, Li Z. Apolipoprotein A1 and heterogeneous nuclear ribonucleoprotein E1 implicated in the regulation of embryo implantation by inhibiting lipid peroxidation. Reprod Biomed Online. 2016;33(5):635\u201345.","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"3734_CR47","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","volume":"14","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sarin SK, Wong VW, Fan JG, Kawaguchi T, Ahn SH, et al. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int. 2020;14(6):889\u2013919.","journal-title":"Hepatol Int"},{"issue":"29","key":"3734_CR48","doi-asserted-by":"publisher","first-page":"30490","DOI":"10.1074\/jbc.M403920200","volume":"279","author":"T Yamaguchi","year":"2004","unstructured":"Yamaguchi T, Omatsu N, Matsushita S, Osumi T. CGI-58 interacts with perilipin and is localized to lipid droplets. Possible involvement of CGI-58 mislocalization in Chanarin-Dorfman syndrome. J Biol Chem. 2004;279(29):30490\u20137.","journal-title":"J Biol Chem"},{"issue":"47","key":"3734_CR49","doi-asserted-by":"publisher","first-page":"32359","DOI":"10.1074\/jbc.M109.061515","volume":"284","author":"A Gubern","year":"2009","unstructured":"Gubern A, Barcelo-Torns M, Barneda D, Lopez JM, Masgrau R, Picatoste F, et al. JNK and ceramide kinase govern the biogenesis of lipid droplets through activation of group IVA phospholipase A2. J Biol Chem. 2009;284(47):32359\u201369.","journal-title":"J Biol Chem"},{"issue":"19","key":"3734_CR50","doi-asserted-by":"publisher","first-page":"10460","DOI":"10.3390\/ijms221910460","volume":"22","author":"L Frances","year":"2021","unstructured":"Frances L, Tavernier G, Viguerie N. Adipose-Derived Lipid-Binding Proteins: The Good, the Bad and the Metabolic Diseases. Int J Mol Sci. 2021;22(19):10460.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"3734_CR51","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1161\/CIRCRESAHA.118.311227","volume":"122","author":"MD Shapiro","year":"2018","unstructured":"Shapiro MD, Tavori H, Fazio S. PCSK9: from basic science discoveries to clinical trials. Circ Res. 2018;122(10):1420\u201338.","journal-title":"Circ Res"},{"issue":"1","key":"3734_CR52","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bcp.2014.07.002","volume":"91","author":"ZF Zhang","year":"2014","unstructured":"Zhang ZF, Fan SH, Zheng YL, Lu J, Wu DM, Shan Q, et al. Troxerutin improves hepatic lipid homeostasis by restoring NAD(+)-depletion-mediated dysfunction of lipin 1 signaling in high-fat diet-treated mice. Biochem Pharmacol. 2014;91(1):74\u201386.","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"3734_CR53","doi-asserted-by":"publisher","first-page":"E1234","DOI":"10.1152\/ajpendo.00198.2012","volume":"303","author":"H Li","year":"2012","unstructured":"Li H, Xu M, Lee J, He C, Xie Z. Leucine supplementation increases SIRT1 expression and prevents mitochondrial dysfunction and metabolic disorders in high-fat diet-induced obese mice. Am J Physiol Endocrinol Metab. 2012;303(10):E1234-1244.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"16","key":"3734_CR54","doi-asserted-by":"publisher","first-page":"14681","DOI":"10.1074\/jbc.M110.201061","volume":"286","author":"R Tao","year":"2011","unstructured":"Tao R, Wei D, Gao H, Liu Y, DePinho RA, Dong XC. Hepatic FoxOs regulate lipid metabolism via modulation of expression of the nicotinamide phosphoribosyltransferase gene. J Biol Chem. 2011;286(16):14681\u201390.","journal-title":"J Biol Chem"},{"issue":"9","key":"3734_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000196","volume":"7","author":"D Bogani","year":"2009","unstructured":"Bogani D, Siggers P, Brixey R, Warr N, Beddow S, Edwards J, et al. Loss of mitogen-activated protein kinase kinase kinase 4 (MAP3K4) reveals a requirement for MAPK signalling in mouse sex determination. PLoS Biol. 2009;7(9): e1000196.","journal-title":"PLoS Biol"},{"issue":"6824","key":"3734_CR56","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/35065000","volume":"410","author":"L Chang","year":"2001","unstructured":"Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature. 2001;410(6824):37\u201340.","journal-title":"Nature"},{"issue":"3","key":"3734_CR57","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.smim.2014.02.009","volume":"26","author":"G Sabio","year":"2014","unstructured":"Sabio G, Davis RJ. TNF and MAP kinase signalling pathways. Semin Immunol. 2014;26(3):237\u201345.","journal-title":"Semin Immunol"},{"issue":"12","key":"3734_CR58","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.1210\/jc.2006-0587","volume":"91","author":"KM Utzschneider","year":"2006","unstructured":"Utzschneider KM, Kahn SE. Review: the role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2006;91(12):4753\u201361.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4\u20135","key":"3734_CR59","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/15216540500097111","volume":"57","author":"M Karin","year":"2005","unstructured":"Karin M, Gallagher E. From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life. 2005;57(4\u20135):283\u201395.","journal-title":"IUBMB Life"},{"issue":"3","key":"3734_CR60","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.30306","volume":"69","author":"A Cooreman","year":"2019","unstructured":"Cooreman A, Van Campenhout R, Ballet S, Annaert P, Van Den Bossche B, Colle I, et al. Connexin and Pannexin (Hemi)channels: emerging targets in the treatment of liver disease. Hepatology. 2019;69(3):1317\u201323.","journal-title":"Hepatology"},{"issue":"12","key":"3734_CR61","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1007\/s00204-020-02873-5","volume":"94","author":"A Naiki-Ito","year":"2020","unstructured":"Naiki-Ito A, Kato H, Naiki T, Yeewa R, Aoyama Y, Nagayasu Y, et al. A novel model of non-alcoholic steatohepatitis with fibrosis and carcinogenesis in connexin 32 dominant-negative transgenic rats. Arch Toxicol. 2020;94(12):4085\u201397.","journal-title":"Arch Toxicol"},{"issue":"10","key":"3734_CR62","doi-asserted-by":"publisher","first-page":"C1034","DOI":"10.1152\/ajpcell.00175.2012","volume":"303","author":"F Xiao","year":"2012","unstructured":"Xiao F, Waldrop SL, Khimji AK, Kilic G. Pannexin1 contributes to pathophysiological ATP release in lipoapoptosis induced by saturated free fatty acids in liver cells. Am J Physiol Cell Physiol. 2012;303(10):C1034-1044.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"41","key":"3734_CR63","doi-asserted-by":"publisher","first-page":"27369","DOI":"10.1074\/jbc.M800696200","volume":"283","author":"A Gubern","year":"2008","unstructured":"Gubern A, Casas J, Barcelo-Torns M, Barneda D, de la Rosa X, Masgrau R, et al. Group IVA phospholipase A2 is necessary for the biogenesis of lipid droplets. J Biol Chem. 2008;283(41):27369\u201382.","journal-title":"J Biol Chem"},{"issue":"6","key":"3734_CR64","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.plipres.2006.05.003","volume":"45","author":"M Ghosh","year":"2006","unstructured":"Ghosh M, Tucker DE, Burchett SA, Leslie CC. Properties of the Group IV phospholipase A2 family. Prog Lipid Res. 2006;45(6):487\u2013510.","journal-title":"Prog Lipid Res"},{"issue":"9","key":"3734_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102310","volume":"298","author":"CH Perry","year":"2022","unstructured":"Perry CH, Mullins NA, Sweileh RBA, Shendy NAM, Roberto PA, Broadhurst AL, et al. MAP3K4 promotes fetal and placental growth by controlling the receptor tyrosine kinases IGF1R\/IR and Akt signaling pathway. J Biol Chem. 2022;298(9): 102310.","journal-title":"J Biol Chem"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03734-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-022-03734-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-022-03734-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T01:14:47Z","timestamp":1668647687000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-022-03734-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,14]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3734"],"URL":"https:\/\/doi.org\/10.1186\/s12967-022-03734-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,14]]},"assertion":[{"value":"8 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients gave informed consent, and the study protocol was approved by the ethics committee of the Second Xiangya Hospital of Central South University (No.2019-050).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the content and agree to submit for consideration for publication in the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"529"}}